Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease b-cell lymphomas
Comorbidity C0019158|hepatitis
Sentences 9
PubMedID- 24270404 Outcome prediction of diffuse large b-cell lymphomas associated with hepatitis c virus infection: a study on behalf of the fondazione italiana linfomi.
PubMedID- 22736295 Clinical outcome in diffuse large b-cell lymphoma with hepatitis c virus infection in the rituximab era: a single center experience.
PubMedID- 20554488 Hcv-positive status and hepatitis flares in patients with b-cell non-hodgkin's lymphoma treated with rituximab-containing regimens.
PubMedID- 25381127 The notch pathway is recurrently mutated in diffuse large b-cell lymphoma associated with hepatitis c virus infection.
PubMedID- 22395482 b-cell lymphoma in hepatitis c virus (hcv)-seropositive patients frequently presents with extranodal disease in the bone marrow, major salivary glands, or spleen [1, 2].
PubMedID- 24060287 Bendamustine and rituximab for indolent b-cell non-hodgkin lymphoma in patients with compensated hepatitis c cirrhosis: a case series.
PubMedID- 25339404 Fatal outcome of autochthonous hepatitis e in a patient with b cell lymphoma in southeastern france.
PubMedID- 25848698 We performed a retrospective study to analyse the characteristics and clinical outcomes of diffuse large b-cell lymphoma (dlbcl) patients with hepatitis b virus (hbv) infection and compare with those without hbv infection.
PubMedID- 23465418 Early-stage splenic diffuse large b-cell lymphoma is highly associated with hepatitis c virus infection.

Page: 1